Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation
This Viewpoint describes the need for more studies on the best timing for dicontinuation of glucagon-like peptide-1 receptor agonists before pregnancy.
Authors
- Dhruv S. Kazi (ORCID: https://orcid.org/0000-0002-9510-2979)
- William A. Grobman (ORCID: https://orcid.org/0000-0002-3979-0738)
- Sadiya S. Khan (ORCID: https://orcid.org/0000-0003-0643-1859)
Institutions
- Northwestern University (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Brown University (US)
- Deaconess Hospital (US)
Publication Details
- Journal
- JAMA Cardiology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1001/jamacardio.2025.0637
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00